1
|
Gomez Limia CE, Devalle S, Reis M, Sochacki J, Carneiro M, Madeiro da Costa R, D'Andrea M, Padilha T, Zalcberg IR, Solza C, Daumas A, Rehen S, Monte-Mór B, Bonamino MH. Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation. Stem Cell Res 2017; 24:16-20. [PMID: 29034885 DOI: 10.1016/j.scr.2017.08.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Revised: 07/26/2017] [Accepted: 08/03/2017] [Indexed: 01/14/2023] Open
Abstract
Peripheral blood sample was donated by a 61years old female patient diagnosed with acute myeloid leukemia secondary to a primary myelofibrosis harboring the 52-bp deletion in the CALR gene (c.1092_1143del, p.L367fs*46) and the R693X mutation in the ASXL1 gene (c.2077C>T, p.R693X). CD34+ cells were isolated from the sample and subjected to the reprogramming procedure by using the Sendai virus carrying the reprogramming factors Oct3/4, Sox2, Klf4 and c-Myc. iPS colonies generated retained the original mutations and displayed all the features of bona fide iPS cells.
Collapse
Affiliation(s)
- Cintia E Gomez Limia
- Molecular Carcinogenesis Program, Research Coordination, Brazilian National Cancer Institute (INCA), Rua André Cavalcante 37, Rio de Janeiro 20230-240, Brazil
| | - Sylvie Devalle
- D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro 22281-100, Brazil
| | - Marcelo Reis
- D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro 22281-100, Brazil
| | - Jaroslaw Sochacki
- D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro 22281-100, Brazil
| | - Mayra Carneiro
- Molecular Carcinogenesis Program, Research Coordination, Brazilian National Cancer Institute (INCA), Rua André Cavalcante 37, Rio de Janeiro 20230-240, Brazil
| | - Rodrigo Madeiro da Costa
- D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro 22281-100, Brazil
| | - Mariana D'Andrea
- Laboratory of Molecular Biology, Bone Marrow Transplant Center (CEMO), Brazilian National Cancer Institute (INCA), Praça Cruz Vermelha, 23, Rio de Janeiro 20230-130, Brazil
| | - Telma Padilha
- Laboratory of Molecular Biology, Bone Marrow Transplant Center (CEMO), Brazilian National Cancer Institute (INCA), Praça Cruz Vermelha, 23, Rio de Janeiro 20230-130, Brazil
| | - Ilana R Zalcberg
- Laboratory of Molecular Biology, Bone Marrow Transplant Center (CEMO), Brazilian National Cancer Institute (INCA), Praça Cruz Vermelha, 23, Rio de Janeiro 20230-130, Brazil
| | - Cristiana Solza
- Pedro Ernesto University Hospital (HUPE), University of the State of Rio de Janeiro (UERJ), Boulevard 28 de Setembro, 77, Rio de Janeiro 20551-030, Brazil
| | - Adelmo Daumas
- Antônio Pedro University Hospital (HUAP), Fluminense Federal University (UFF), Rua Marques de Paraná, 303, Niterói 24033-900, Brazil
| | - Stevens Rehen
- D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Rio de Janeiro 22281-100, Brazil; Institute of Biomedical Sciences, Federal University of Rio de Janeiro (UFRJ), Avenida Carlos Chagas 373, Rio de Janeiro 21941-590, Brazil
| | - Bárbara Monte-Mór
- Laboratory of Molecular Biology, Bone Marrow Transplant Center (CEMO), Brazilian National Cancer Institute (INCA), Praça Cruz Vermelha, 23, Rio de Janeiro 20230-130, Brazil.
| | - Martín H Bonamino
- Molecular Carcinogenesis Program, Research Coordination, Brazilian National Cancer Institute (INCA), Rua André Cavalcante 37, Rio de Janeiro 20230-240, Brazil; FIOCRUZ - Oswaldo Cruz Foundation Institute, Avenida Brasil 4365 - Manguinhos, Rio de Janeiro 21040-360, Brazil.
| |
Collapse
|